Authors:K. Kis, P. Taylor, G. Wittmann, B. Toronyi, and S. Puszta
In this study we interpret the magnetic anomalies at satellite altitude over a part of Europe and the Pannonian Basin. These anomalies are derived from the total magnetic measurements from the CHAMP satellite. The anomalies are reduced to an elevation of 324 km. An inversion method is used to interpret the total magnetic anomalies over the Pannonian Basin. A three dimensional triangular model is used in the inversion. Two parameter distributions, Laplacian and Gaussian are investigated. The regularized inversion is numerically calculated with the Simplex and Simulated Annealing methods and the anomalous source is located in the upper crust. A probable source of the magnetization is due to the exsolution of the hematite-ilmenite minerals.
Authors:K. I. Kis, P. T. Taylor, G. Wittmann, H. R. Kim, B. Toronyi, and T. Mayer-Gürr
To solve a geophysical inverse problem means applying measurements to determine the parameters of the selected model. The inverse problem is formulated as the Bayesian inference. The Gaussian probability density functions are applied in the Bayes's equation. The CHAMP satellite gravity data are determined at the altitude of 400 km altitude over the South part of the Pannonian Basin. The model of interpretation is the right vertical cylinder. The parameters of the model are obtained from the minimum problem solved by the Simplex method.
Authors:Balázs Nemes, É. Toronyi, K. Rajczy, A. Szakos, B. Somlai, A. Doros, R. Chmel, F. Derner, and L. Kóbori
Malignant diseases are considered as great challenges in clinical transplantation. It is well known that the incidence of malignancy is higher in the transplanted population if compared with the normal population. It is important to distinguish between neoplastic diseases originating from pre-existing lesions in the transplanted organs and de novo graft tumours. Post-transplant malignancy of donor origin is a rare complication of organ transplantation, most likely transmitted as micrometastases within the parenchyma of the donor organ or from circulating tumour cells contained within the organ. Malignant melanoma, although its incidence is rather low, is one of the most common donor-derived tumour inadvertently transplanted, comprising 28% of donor transmitted tumours. Malignant melanoma in the graft without dermatological localisation is extremely rare. We report a case of de novo melanoma occurring in the allograft, where transmission from the donor was excluded by DNA (desoxyribonucleic acid) investigation. We did not find any data in the literature where a malignant melanoma occurred after transplantation in the transplanted kidney without any skin lesions and the donor origin was excluded. We draw attention to the importance of the DNA typing in case of tumours occurring in immunosuppressed patients.